934715-75-0

Upstream product

• 13139-15-6 N-tert-butoxycarbonyl-L-leucine 
• 909108-99-2 Boc-D-Leu-L-MeLeu-OMe 
• 160410-51-5 Boc-D-Leu-L-MeLeu-OH 
• 16937-99-8 N-Boc-D-Leu 
• 35026-08-5 N-methyl-L-leucine methyl ester 
• 909108-97-0 (R)-2-[(S)-2-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester 
• 934715-24-9 (R)-2-[(S)-2-((S)-2-Amino-3-methyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester 
• 934715-25-0 2-[2-(2-{2-[(2-tert-butoxycarbonylamino-4-methyl-pentanoyl)-methyl-amino]-4-methyl-pentanoylamino}-3-methyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester 
• 735202-70-7 L-Leu-D-Phe-OMe 
• 15136-32-0 Boc-L-Leu-D-Phe-OMe 
• 21685-51-8 D-phenylalanine methyl ester 

Downstream Products

• 1006104-44-4 C₆₆H₁₀₆N₁₀O₁₀ 

Relevant academic research and scientific papers

Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles

(Chemical Equation Presented) Described are the syntheses of five decapeptides that are C-2-symmetrical derivatives of the natural product pentapeptide sansalvamide A. Derivatives were made using a succinct convergent synthesis. These analogues share no s

Synthesis of second-generation Sansalvamide A derivatives: Novel templates as potential antitumor agents

We report the synthesis of 34 second-generation Sansalvamide A derivatives. San A derivatives have unique anticancer properties and target multiple cancers, including colon, pancreatic, breast, prostate, and melanoma. As novel templates, the derivatives d